Sore Throat with Burning Sensation After Unprotected Oral Sex
This patient requires immediate testing for gonococcal and chlamydial pharyngitis, and should receive empiric treatment with ceftriaxone 250 mg IM plus azithromycin 1 g orally as a single dose while awaiting results.
Clinical Context and Diagnostic Approach
A sore, burning throat following unprotected oral sex raises immediate concern for sexually transmitted pharyngeal infections, particularly gonococcal pharyngitis and Chlamydia trachomatis pharyngitis. These infections are frequently asymptomatic but can present with pharyngitis symptoms 1, 2, 3. The burning sensation is consistent with inflammatory pharyngitis from these pathogens.
Key Historical Details to Obtain:
- Timing: Symptoms typically appear within days to 2 weeks post-exposure 4
- Type of sexual contact: Fellatio, cunnilingus, or anilingus (all can transmit STIs) 1, 3
- Partner's symptoms or known infections: Critical for risk assessment
- Previous STI history: Increases likelihood of current infection
- HIV status: Affects treatment considerations
Physical Examination Findings to Look For:
- Pharyngeal erythema and exudate
- Tonsillar involvement
- Oral ulcers, plaques, or papules (may indicate syphilis, HSV, or HPV) 5, 1
- Cervical lymphadenopathy
- Examine tongue, commissures, and palate specifically 5
- Inspect genital and anal regions even if asymptomatic—concurrent infections are common 6
Diagnostic Testing
Obtain NAATs (nucleic acid amplification tests) from the pharynx for both N. gonorrhoeae and C. trachomatis 7. These are the preferred diagnostic tests for pharyngeal STIs.
Additional testing should include:
- Serum testing for HIV, syphilis, and hepatitis B 7
- Consider testing for HSV if ulcerative lesions present 1, 2
Critical caveat: Pharyngeal gonorrhea and chlamydia are asymptomatic in the majority of cases but serve as important reservoirs for transmission 2, 3. The presence of symptoms actually increases diagnostic suspicion.
Treatment Recommendations
Empiric Treatment (Start Immediately)
The recommended regimen is ceftriaxone 250 mg IM in a single dose PLUS azithromycin 1 g orally in a single dose 7. This is based on the 2015 CDC STD Treatment Guidelines, which represent the most recent guideline evidence provided.
Rationale for empiric treatment:
- Pharyngeal gonorrhea is more difficult to eradicate than urogenital infections—few regimens achieve >90% cure rates 8, 6, 8
- Ceftriaxone is the most reliable agent for pharyngeal gonorrhea 6
- Azithromycin covers chlamydia (which commonly coinfects at genital sites even if pharyngeal coinfection is rare) 8, 6, 8
- Compliance with follow-up is often poor, making empiric treatment essential 7
Important Treatment Considerations:
Do NOT use quinolones (ciprofloxacin, ofloxacin) if:
- Patient is a man who has sex with men (MSM)
- Recent travel history (patient or partner)
- Infection acquired in areas with high quinolone-resistant N. gonorrhoeae (QRNG) prevalence 6
Given the age of the older guidelines (2002-2006) and increasing antibiotic resistance patterns, ceftriaxone is the safest first-line choice regardless of patient demographics.
Alternative Regimens:
If cephalosporin allergy exists, spectinomycin 2 g IM can be used, but it is only 52% effective against pharyngeal infections and requires follow-up pharyngeal culture 3-5 days post-treatment to verify cure 8.
Partner Management
All sexual partners within 60 days before symptom onset must be evaluated and treated for both gonorrhea and chlamydia 8, 6. If last sexual contact was >60 days ago, treat the most recent partner 6.
- Instruct patient to abstain from sexual activity until treatment is completed and both patient and partners are asymptomatic 6
- Consider expedited partner therapy (providing medication directly to partners) if partner evaluation is unlikely, though this is less ideal for pharyngeal infections 6
Follow-Up
Test of cure is NOT routinely needed if treated with recommended regimens 6. However:
- If symptoms persist after treatment, obtain culture with antimicrobial susceptibility testing 8, 6, 8
- Retest in 3 months due to high reinfection rates (most post-treatment infections are reinfections, not treatment failures) 6
- Persistent symptoms may indicate C. trachomatis or other organisms 8, 6
Additional Screening
Given the sexual exposure, also screen for:
- Syphilis (can cause oral ulcers and pharyngitis) 1, 2
- HSV (if vesicular or ulcerative lesions) 1, 2
- HIV (acute HIV can present with pharyngitis) 2
- HPV-related lesions (condyloma, papillomas—though typically not acutely symptomatic) 5, 1
Common Pitfalls to Avoid
- Failing to test the pharynx: Many clinicians only test genital sites
- Using inadequate antibiotics: Pharyngeal gonorrhea requires specific regimens
- Not treating partners: This perpetuates transmission cycles
- Assuming negative tests rule out infection: Testing too early may miss infections
- Overlooking asymptomatic genital coinfection: Always examine and test all potentially exposed sites 6